Cargando…

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection

Primary infection with the Omicron variant of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) can be serologically identified with distinct profiles of neutralizing antibodies (nAbs), as indicated by high titers against the Omicron variant and low titers against the ancestral wild-type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Springer, David Niklas, Traugott, Marianna, Reuberger, Elisabeth, Kothbauer, Klaus Benjamin, Borsodi, Christian, Nägeli, Michelle, Oelschlägel, Theresa, Kelani, Hasan, Lammel, Oliver, Deutsch, Josef, Puchhammer-Stöckl, Elisabeth, Höltl, Eva, Aberle, Judith Helene, Stiasny, Karin, Weseslindtner, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341213/ https://www.ncbi.nlm.nih.gov/pubmed/37443672 http://dx.doi.org/10.3390/diagnostics13132278

Ejemplares similares

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
por: Graninger, Marianne, et al.
Publicado: (2023)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
por: Medits, Iris, et al.
Publicado: (2022)

Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
por: Springer, David Niklas, et al.
Publicado: (2022)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
por: Graninger, Marianne, et al.
Publicado: (2022)

Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
por: Springer, David N., et al.
Publicado: (2023)

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
por: Semmler, Georg, et al.
Publicado: (2021)

Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
por: Traugott, Marianna Theresia, et al.
Publicado: (2020)

Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
por: Sieber, Justyna, et al.
Publicado: (2022)

Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2021)

Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity
por: Koblischke, Maximilian, et al.
Publicado: (2020)

SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
por: Stiasny, Karin, et al.
Publicado: (2022)

Dissection of the NKG2C NK cell response against Puumala Orthohantavirus
por: Vietzen, Hannes, et al.
Publicado: (2021)

Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria
por: Redlberger-Fritz, Monika, et al.
Publicado: (2021)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

Effect of vaccine dosing intervals on Omicron surrogate neutralization after three doses of BNT162b2
por: Prusinkiewicz, Martin A., et al.
Publicado: (2023)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
por: Breyer, Marie-Kathrin, et al.
Publicado: (2021)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
por: Wang, Xue-Jun, et al.
Publicado: (2022)

The natural killer cell‐associated rs9916629‐C allele is a novel genetic risk factor for fatal COVID‐19
por: Vietzen, Hannes, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Neutralization, effector function and immune imprinting of Omicron variants
por: Addetia, Amin, et al.
Publicado: (2023)

Standardisation and controls, why can’t we overcome the hurdles?
por: Niesters, Hubert G.M., et al.
Publicado: (2004)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
por: Kim, Sun Jin, et al.
Publicado: (2022)

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
por: Vaidya, Sunil R.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
por: Buchta, Christoph, et al.
Publicado: (2023)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

Structures of Omicron spike complexes and implications for neutralizing antibody development
por: Guo, Hangtian, et al.
Publicado: (2022)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Multivariate analysis techniques for neutral pileup suppression in Particle Flow
por: Luthi, Melina
Publicado: (2018)

RT-PCR based SARS-CoV-2 variant screening assays require careful quality control
por: Camp, Jeremy V., et al.
Publicado: (2021)

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
por: Zou, Jing, et al.
Publicado: (2022)

Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level
por: Wang, Xiaoli, et al.
Publicado: (2018)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a50ukid8bh9i650a78ci2ucp23